AAAAAA

   
Results: 1-13 |
Results: 13

Authors: Corrigall, VM Bodman-Smith, MD Fife, MS Canas, B Myers, LK Wooley, PH Soh, C Staines, NA Pappin, DJC Berlo, SE van Eden, W van der Zee, R Lanchbury, JS Panayi, GS
Citation: Vm. Corrigall et al., The human endoplasmic reticulum molecular chaperone BiP is an autoantigen for rheumatoid arthritis and prevents the induction of experimental arthritis, J IMMUNOL, 166(3), 2001, pp. 1492-1498

Authors: Myers, LK Higgins, GC Finkel, TH Reed, AM Thompson, JW Walton, RC Hendrickson, J Kerr, NC Pandya-Lipman, RK Shlopov, BV Stastny, P Postlethwaite, AE Kang, AH
Citation: Lk. Myers et al., Juvenile arthritis and autoimmunity to type II collagen, ARTH RHEUM, 44(8), 2001, pp. 1775-1781

Authors: Kalmin, ND Myers, LK Fisk, MB
Citation: Nd. Kalmin et al., ISO 9000 model ideally suited for quality plan at blood centers. (vol 38, pg 79, 1998), TRANSFUSION, 40(2), 2000, pp. 260-260

Authors: Sangster, MY Topham, DJ D'Costa, S Cardin, RD Marion, TN Myers, LK Doherty, PC
Citation: My. Sangster et al., Analysis of the virus-specific and nonspecific B cell response to a persistent B-lymphotropic gammaherpesvirus, J IMMUNOL, 164(4), 2000, pp. 1820-1828

Authors: Tang, B Brand, DD Chiang, TM Stuart, JM Kang, AH Myers, LK
Citation: B. Tang et al., Immunogenicity and arthritogenicity of recombinant CB10 in B10.RIII mice, J IMMUNOL, 164(1), 2000, pp. 481-487

Authors: Myers, LK Kang, AH Postlethwaite, AE Rosloniec, EF Morham, SG Shlopov, BV Goorha, S Ballou, LR
Citation: Lk. Myers et al., The genetic ablation of cyclooxygenase 2 prevents the development of autoimmune arthritis, ARTH RHEUM, 43(12), 2000, pp. 2687-2693

Authors: Tang, B Chiang, TM Brand, DD Gumanovskaya, ML Stuart, JM Kang, AH Myers, LK
Citation: B. Tang et al., Molecular definition and characterization of recombinant bovine CB8 and CB10: Immunogenicity and arthritogenicity, CLIN IMMUNO, 92(3), 1999, pp. 256-264

Authors: Myers, LK Kalmin, ND Fisk, MB
Citation: Lk. Myers et al., ISO 9002: Impact on a blood and tissue center's operation, TR MED REV, 13(3), 1999, pp. 187-193

Authors: Lew, DB Higgins, GC Skinner, RB Snider, MD Myers, LK
Citation: Db. Lew et al., Adverse reaction to prednisone in a patient with systemic lupus erythematosus, PEDIAT DERM, 16(2), 1999, pp. 146-150

Authors: Gumanovskaya, ML Myers, LK Roslniec, EF Stuart, JM Kang, AH
Citation: Ml. Gumanovskaya et al., Intravenous tolerization with type II collagen induces interleukin-4-and interleukin-10-producing CD4(+) T cells, IMMUNOLOGY, 97(3), 1999, pp. 466-473

Authors: McKown, KM Carbone, LD Kaplan, SB Aelion, JA Lohr, KM Cremer, MA Bustillo, J Gonzalez, M Kaeley, G Steere, EL Somes, GW Myers, LK Seyer, JM Kang, AH Postlethwaite, AE
Citation: Km. Mckown et al., Lack of efficacy of oral bovine type II collagen added to existing therapyin rheumatoid arthritis, ARTH RHEUM, 42(6), 1999, pp. 1204-1208

Authors: Kang, ES Tevlin, MT Wang, YB Chiang, TM Cardenas, R Myers, LK Acchiardo, SR
Citation: Es. Kang et al., Hemodialysis hypotension: Interaction of inhibitors, iNOS, and the interdialytic period, AM J MED SC, 317(1), 1999, pp. 9-21

Authors: Myers, LK Brand, DD Ye, XJ Cremer, MA Rosloniec, EF Bodo, M Myllyharju, J Helaakoski, T Nokelainen, M Pihlajaniemi, T Kivirikko, K Yang, CL Alakokko, L Prockop, DJ Notbohm, H Fietzek, P Stuart, JM Kang, AH
Citation: Lk. Myers et al., Characterization of recombinant type II collagen: arthritogenicity and tolerogenicity in DBA/1 mice, IMMUNOLOGY, 95(4), 1998, pp. 631-639
Risultati: 1-13 |